Covid-19 y su repercusión en las adicciones

  1. Sixto Costoya, Andrea 1
  2. Lucas Domínguez, Rut 2
  3. Agulló Calatayud, Víctor 3
  1. 1 Unidad de Investigación Social y Sanitaria UISYS (CSIC-Universitat de València) y Departamento de Historia de la Ciencia y Documentación. Facultad de Medicina, Universitat de València, España,
  2. 2 Unidad de Investigación Social y Sanitaria UISYS (CSIC-Universitat de València), Departamento de Historia de la Ciencia y Documentación. Facultad de Medicina, Universitat de València, España y CIBERONC, España,
  3. 3 Unidad de Investigación Social y Sanitaria UISYS (CSIC-Universitat de València) y Departamento de Sociología y Antropología Social. Facultad de Ciencias Sociales, Universitat de València, España
Mostrar afiliacións +
Revista:
Health and addictions: salud y drogas

ISSN: 1578-5319

Ano de publicación: 2021

Volume: 21

Número: 1

Páxinas: 259-278

Tipo: Artigo

DOI: 10.21134/HAAJ.V21I1.582 DIALNET GOOGLE SCHOLAR lock_openAcceso aberto editor

Outras publicacións en: Health and addictions: salud y drogas

Resumo

Objective. Inquire about the emerging scientific literature at the international level about the repercussion of the COVID-19 pandemic on addictions. Methodology. The Web of Science database was used to analyze the scientific literature on the COVID-19 pandemic and its influence in the field of addictions. Results. 320 documents were identified, of which 38 met the inclusion criteria. Three problems stood out: the consumption of tobacco, opioids and alcohol. According to the incipient literature, among opioid users there is a risk of increased overdoses, as well as a worsening of the stress-alcohol binomial and a worse prognosis of COVID-19 disease for tobacco smokers, the latter with some controversy. The concern about the decrease in health services focused on addictions and mental health stands out. Conclusions. The literature is very emergent and more scientific evidence is needed to shed light. The concern about alcohol, opioids and tobacco is evident, but the absence of studies on addictions without substance (new technologies, online gambling) or hypnotics and benzodiazepines is confirmed.

Referencias bibliográficas

  • Ahmed, M. Z., Ahmed, O., Aibao, Z., Hanbin, S., Siyu, L., Ahmad, A. (2020). Epidemic of COVID-19 in China and associated Psychological Problems. Asian Journal of Psychiatry, 51, 102092.
  • Alexander, G. C., Stoller, K. B., Haffajee, R. L., Saloner, B. (2020). An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19. Annals of Internal Medicine, 19–21.
  • Arya, S., Gupta, R. (2020). COVID-19 outbreak: Challenges for Addiction services in India. Asian Journal of Psychiatry, 51(March), 102086.
  • Bansal, P., Bingemann, T. A., Greenhawt, M., Mosnaim, G., Nanda, A., Oppenheimer, J.,Shaker, M. (2020). Clinician Wellness During the COVID-19 Pandemic: Extraordinary Times and Unusual Challenges for the Allergist/Immunologist. The Journal of Allergy and Clinical Immunology: In Practice, 8(6), 1781-1790.e3.
  • Becker, W., Fiellin, D. (2020). When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis William. Annals of Internal Medicine, 1–3.
  • Brake, S. J., Barnsley, K., Lu, W., McAlinden, K. D., Eapen, M. S., Sohal, S. S. (2020). Smoking Upregulates Angiotensin Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19). Journal of Clinical Medicine, 9(3), 841.
  • Cai, G., Bossé, Y., Xiao, F., Kheradmand, F. (2020). Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2. American Journal of Respiratory and Critical Care Medicine, 201(12), 1–11.
  • Carrico, A. W., Horvath, K. J., Grov, C., Moskowitz, J. T., Pahwa, S., Pallikkuth, S., Hirshfield, S. (2020). Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19. AIDS and Behavior, (0123456789), 1–4.
  • Clay, J. M., Parker, M. O. (2020). Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis? The Lancet Public Health, 5(5), 30088–8.
  • da Silva, A. C. L., Martelli, H., Ferreti, P. R., Kowalskie, L. P., da Cruz, D. E. (2020). COVID-19, head and neck cancer, and the need of training of health students and practitioners regarding to tobacco control and patient counseling. Oral Oncology, 106.
  • Dunlop, A., Lokuge, B., Masters, D., Sequeira, M., Saul, P., Dunlop, G.,Maher, L. (2020). Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic. Harm Reduction Journal, 17(26).
  • Editorial. (2020). The COVID-19 pandemic and mental health impacts. International Journal of Mental Health Nursing, 29, 315-318.
  • García, L., de la Fuente, L., Sáiz, P. A., García, M. P., & Bobes, J. (2020). ¿Se observarán cambios en el consumo de alcohol y tabaco durante el confinamiento por COVID-19? Adicciones, 32(2), 85–89.
  • Gurmeet, A., Mds, S., Surgery, M., Glasgow, M. (2020). Tobacco use and vaping in the COVID-19 era. Head & Neck, 42(6), 1–3.
  • Hefler, M., Gartner, C. E. (2020). The tobacco industry in the time of COVID-19: time to shut it down? Tobacco Control, 29(3), 245-246.
  • Jenkins, W. D., Bolinski, R., Bresett, J., Ham, B. V., Fletcher, S., Walters, S., Ouellet, L. (2020). COVID-19 During the Opioid Epidemic – Exacerbation of Stigma and Vulnerabilities. The Journal of Rural Health, (March), 1–3.
  • Kar, S. K., Arafat, S. M. Y., Sharma, P., Dixit, A., Marthoenis, M., Kabir, R. (2020). COVID-19 pandemic and addiction: Current problems and future concerns. Asian Journal of Psychiatry, 51.
  • Kaur, J.,Rinkoo, A. V. (2020). Public health perspectives of smokeless tobacco and areca nut use in the COVID-19 era. Nicotine & Tobacco Research, xx(xx) 1–2.
  • King, D. L., Delfabbro, P. H., Billieux, J., Potenza, M. N. (2020). Problematic online gaming and the COVID-19 pandemic. Journal of Behavioral Addictions, 9(2), 184-186.
  • Lazcano, E., Alpuche, C. (2020). Alfabetización en salud pública ante la emergencia de la pandemia por Covid-19. Salud Pública de México, 62(3), 331–340.
  • Lee, S. A. (2020). Coronavirus anxiety scale: A brief mental health screener for COVID-19 related anxiety. Death Studies, 44(7), 393-401.
  • Lima, N. N. R., de Souza, R. I., Gomes, P. W., de Sousa, J. L., Lima da Silva, C. G.,Neto, M. L. R. (2020). People experiencing homelessness: Their potential exposure to COVID-19. Psychiatry Research, 288, 1-2.
  • Lippi, G., Henry, B. M., Bovo, C., Sanchis, F. (2020). Health risks and potential remedies during prolonged lockdowns for coronavirus disease 2019 (COVID-19). Diagnosis, 7(2), 85-90.
  • Liu, J. J., Bao, Y., Huang, X., Shi, J., Lu, L. (2020). Mental health considerations for children quarantined because of COVID-19. The Lancet Child & Adolescent Health, 4(5), 347-349.
  • Marsden, J., Darke, S., Hall, W., Hickman, M., Holmes, J., Humphreys, K.,West, R. (2020). Mitigating and learning from the impact of COVID-19 infection on addictive disorders. Addiction, 115(6), 1007-1010.
  • Olds, J. L., Kabbani, N. (2020). Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population? The FEBS Journal, 1–5.
  • Reece, A. S.,Hulse, G. (2020). America Addresses Two Epidemics – Cannabis and Coronavirus and their Interactions: An Ecological Geospatial Study. Journal: BMJ Open, 1-58.
  • Reynolds, J., Wilkinson, C. (2020). Accessibility of ‘essential’ alcohol in the time of COVID-19: Casting light on the blind spots of licensing? Drug and Alcohol Review, 39(4), 7–10.
  • Russo, P., Bonassi, S., Giacconi, R., Malavolta, M., Tomino, C., Maggi, F. (2020). Early View COVID-19 and Smoking. Is Nicotine the Hidden Link? European Respiratory Journal.
  • Sani, G., Janiri, D., Di Nicola, M., Janiri, L., Ferretti, S., Chieffo, D. (2020). Mental health during and after the COVID-19 emergency in Italy. Psychiatry and Clinical Neurosciences, 74(6), 372-373.
  • Satre, D. D., Hirschtritt, M. E., Silverberg, M. J., Sterling, S. A. (2020). Addressing problems with alcohol and other substances among older adults during the COVID-19 pandemic. The American Journal of Geriatric Psychiatry, (28)7, 780-783.
  • Sexton, M. (2020). Cannabis in the Time of Coronavirus Disease 2019: The Yin and Yang of the Endocannabinoid System in Immunocompetence. The Journal of Alternative and Complementary Medicine, 26(6), 444-448.
  • Shalbafan, M., Khademoreza, N. (2020). What we can learn from COVID-19 outbreak in Iran about the importance of alcohol use education. The American Journal of Drug and Alcohol Abuse, 46(3), 1–2.
  • Tindle, H. A., Newhouse, P. A., Freiberg, M. S. (2020). Beyond Smoking Cessation: Investigating Medicinal Nicotine to Prevent and Treat COVID-19. Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco, xx(xx), 1–2.
  • Tsai, J., Wilson, M. (2020). COVID-19: a potential public health problem for homeless populations. The Lancet Public Health, 5(4), e186–e187.
  • Usher, K., Bhullar, N., Jackson, D. (2020). Life in the pandemic: Social isolation and mental health. Journal of Clinical Nursing, 29(15-16), 2756-2757.
  • Vázquez, J., Redolar Ripoll, D. (2020). COVID-19 outbreak impact in Spain: A role for tobacco smoking? Tobacco Induced Diseases, 18, 1–2.
  • Vecchio, S., Ramella, R., Drago, A., Carraro, D., Littlewood, R., Somaini, L. (2020). COVID19 pandemic and people with opioid use disorder: innovation to reduce risk. Psychiatry Research, 289, 113047, 1-2.
  • Volkow, N. D. (2020). Collision of the COVID-19 and Addiction Epidemics. Annals of Internal Medicine, 173(1), 61-62.
  • Wakeman, S. E., Green, T. C., Rich, J. (n.d.). An overdose surge will compound the COVID-19 pandemic if urgent action is not taken. Nature Medicine, 26, 819-820.
  • Wilson, C. G., Ramage, M., Fagan, E. B. (2020). A Primary Care Response to COVID-19 for Patients with an Opioid Use Disorder. The Journal of Rural Health, 1-3.
  • Yang, Y., Li, W., Zhang, Q., Zhang, L., Cheung, T., Xiang, Y. T. (2020). Mental health services for older adults in China during the COVID-19 outbreak. The Lancet Psychiatry, 7(4), e19.
Fonte de datos: Dialnet